|
CDK6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.317600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.764550E-01 |
| Normal-vs-Stage2 |
3.270200E-01 |
| Normal-vs-Stage3 |
3.472600E-01 |
| Normal-vs-Stage4 |
5.828200E-01 |
| Stage1-vs-Stage2 |
7.562600E-01 |
| Stage1-vs-Stage3 |
6.764600E-01 |
| Stage1-vs-Stage4 |
8.024200E-01 |
| Stage2-vs-Stage3 |
8.967400E-01 |
| Stage2-vs-Stage4 |
9.844600E-01 |
| Stage3-vs-Stage4 |
9.375800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.610370E-01 |
| Normal-vs-AfricanAmerican |
2.262300E-02 |
| Normal-vs-Asian |
4.711800E-01 |
| Caucasian-vs-AfricanAmerican |
1.299370E-01 |
| Caucasian-vs-Asian |
3.561800E-01 |
| AfricanAmerican-vs-Asian |
2.189600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.446800E-01 |
| Normal-vs-Female |
1.658670E-03 |
| Male-vs-Female |
5.502800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.610200E-01 |
| Normal-vs-Extreme_Weight |
4.422000E-01 |
| Normal-vs-Obese |
3.124200E-02 |
| Normal-vs-Extreme_Obese |
8.736200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.267200E-01 |
| Normal_Weight-vs-Obese |
8.319200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.517200E-01 |
| Extreme_Weight-vs-Obese |
2.627800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.613400E-01 |
| Obese-vs-Extreme_Obese |
4.095200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.861400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.104700E-03 |
| Normal-vs-Age(61-80Yrs) |
5.855000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.249000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.882620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.697800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.641200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.808220E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.776440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.963200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.064080E-02 |
| Normal-VS-Type2 PRCC |
8.840400E-01 |
| Normal-VS-KIRP CIMP |
6.217400E-01 |
| Normal-VS-Unclassified PRCC |
1.936140E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.112000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.478600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.507200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.277800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.678100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.146200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.583600E-01 |
| Normal-vs-N1 |
3.237800E-01 |
| Normal-vs-N2 |
2.252400E-01 |
| N0-vs-N1 |
2.535000E-01 |
| N0-vs-N2 |
5.544300E-02 |
| N1-vs-N2 |
3.437600E-01 |
|
|
